Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB)

By: Benzinga
Among biotech and emerging pharmaceutical companies, Biogen Idec (NASDAQ: BIIB ), saw the most significant rise in short interest between the May 15 and May 31 settlement dates. The number of shares sold short in Amgen (NASDAQ: AMGN ), Dendreon (NASDAQ: DNDN ), Onyx Pharmaceuticals (NASDAQ:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.